Detailed Information on Publication Record
2019
Pentraxin 3 in Noninvasively Obtained Cervical Fluid Samples from Pregnancies Complicated by Preterm Prelabor Rupture of Membranes
JANKŮ, Petr, Marian KACEROVSKY, Barbora ZEDNIKOVA, Ctirad ANDRYS, Martina KOLACKOVA et. al.Basic information
Original name
Pentraxin 3 in Noninvasively Obtained Cervical Fluid Samples from Pregnancies Complicated by Preterm Prelabor Rupture of Membranes
Authors
JANKŮ, Petr (203 Czech Republic, belonging to the institution), Marian KACEROVSKY (203 Czech Republic, guarantor), Barbora ZEDNIKOVA (203 Czech Republic), Ctirad ANDRYS (203 Czech Republic), Martina KOLACKOVA (203 Czech Republic), Marcela DRAHOSOVA (203 Czech Republic), Lenka PLISKOVA (203 Czech Republic), Helena ZEMLICKOVA (203 Czech Republic), Romana GERYCHOVÁ (203 Czech Republic, belonging to the institution), Ondrej SIMETKA (203 Czech Republic), Petr MATLAK (203 Czech Republic), Bo JACOBSSON (752 Sweden) and Ivana MUSILOVA (203 Czech Republic)
Edition
Fetal Diagnosis and Therapy, Basel, Karger, 2019, 1015-3837
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30214 Obstetrics and gynaecology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.095
RIV identification code
RIV/00216224:14110/19:00112965
Organization unit
Faculty of Medicine
UT WoS
000507387300007
Keywords in English
Inflammation; Microorganism; Pattern recognition receptor; Preterm birth
Tags
International impact, Reviewed
Změněno: 11/5/2020 13:30, Mgr. Tereza Miškechová
Abstract
V originále
Problem: To determine the changes of pentraxin 3 (PTX3) level in noninvasively obtained cervical fluid samples from women with preterm prelabor rupture of membranes (PPROM) based on the presence of microbial invasion of the amniotic cavity (MIAC) and/or intra-amniotic inflammation (IAI), and intra-amniotic infection (the presence of both MIAC and IAI). Methods of Study: A total of 160 women with PPROM were included. Cervical fluid samples were obtained using a Dacron polyester swab and amniotic fluid samples were obtained by transabdominal amniocentesis. Cervical fluid PTX3 levels were assessed using enzyme-linked immunosorbent assay. Results: PTX3 was found in all the cervical fluid samples and its levels were higher in women with MIAC, IAI, and intra-amniotic infection than in women without these conditions. When the women were categorized into four subgroups based on the presence of MIAC and/or IAI, women with intra-amniotic infection had higher cervical fluid PTX3 levels than those with sterile IAI (IAI alone), colonization (MIAC alone), or no MIAC or IAI. A cervical fluid PTX3 level of 11 ng/mL was the best value for identifying the presence of intra-amniotic infection in women with PPROM. Conclusions: PTX3 is a constituent of cervical fluid of women with PPROM. Cervical fluid PTX3 level reflects the situation in the intra-amniotic compartments of women with PPROM. Cervical fluid PTX3 is a potential marker for the noninvasive identification of intra-amniotic infection in PPROM.